SiglecF Expressing Neutrophils Exacerbate Th17-Mediated Autoimmune Neuroinflammation

  • Wonseok Hu
  • , Leezhi Kwon
  • , Yu Sun Jeong
  • , Geon Ho Bae
  • , Ye Seon Kim
  • , Brian A. Zabel
  • , Yoe Sik Bae

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Multiple sclerosis is an autoimmune disease characterized by numerous immune cells, including neutrophils, infiltrating the central nervous system. Previous reports point to a complex role for neutrophils in experimental autoimmune encephalomyelitis (EAE), where their heterogeneity remains poorly understood. In this study, we identified a unique population of neutrophils expressing SiglecF in the brain during EAE that can influence T cell activity. These neutrophils produced elevated levels of Th17-polarizing cytokines, including IL-6, IL-1β, IL-23, and TNF-α, both in vivo and in vitro. Consistent with this cytokine profile, co-culturing SiglecF+ neutrophils with CD4+ T cells promoted Th17 and GM-CSF+ pathogenic Th17 differentiation and proliferation while reducing regulatory T cell numbers. Depleting SiglecF+ neutrophils with anti-SiglecF Abs reduced the severity of EAE, decreased the Th17 population, and increased the regulatory T cell population in the brain. These findings suggest that SiglecF+ neutrophils promote autoimmune neuroinflammation by reinforcing pathogenic autoreactive Th17 cell responses.

Original languageEnglish
Article numbere19
JournalImmune Network
Volume25
Issue number3
DOIs
StatePublished - Jun 2025

Keywords

  • Autoimmune disease
  • Experimental autoimmune encephalomyelitis
  • Neutrophil heterogeneity
  • SiglecF neutrophil
  • Th17 cells

Fingerprint

Dive into the research topics of 'SiglecF Expressing Neutrophils Exacerbate Th17-Mediated Autoimmune Neuroinflammation'. Together they form a unique fingerprint.

Cite this